English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/111499
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Título

A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors

AutorVicente-Dueñas, Carolina; Romero-Camarero, Isabel; González-Herrero, Inés; Abollo-Jiménez, Fernando; Jiang, Xiaoyu; Gutiérrez, Norma Carmen; Orfao, Alberto; Pintado, Belén; Flores, Teresa; Rivas, Javier de las; Jiménez, Rafael; García-Criado, Francisco Javier; García-Cenador, Begoña; Lossos, Izidore S.; Cobaleda, César; Sánchez García, Isidro
Palabras claveCancer therapy
Reprogramming stem cells
Multiple myeloma mouse model
Oncogenes
MafB
Fecha de publicación2012
EditorNature Publishing Group
CitaciónEMBO Journal 31(18): 3704- 3717 (2012)
ResumenUnderstanding the cellular origin of cancer can help to improve disease prevention and therapeutics. Human plasma cell neoplasias are thought to develop from either differentiated B cells or plasma cells. However, when the expression of Maf oncogenes (associated to human plasma cell neoplasias) is targeted to mouse B cells, the resulting animals fail to reproduce the human disease. Here, to explore early cellular changes that might take place in the development of plasma cell neoplasias, we engineered transgenic mice to express MafB in haematopoietic stem/progenitor cells (HS/PCs). Unexpectedly, we show that plasma cell neoplasias arise in the MafB-transgenic mice. Beyond their clinical resemblance to human disease, these neoplasias highly express genes that are known to be upregulated in human multiple myeloma. Moreover, gene expression profiling revealed that MafB-expressing HS/PCs were more similar to B cells and tumour plasma cells than to any other subset, including wild-type HS/PCs. Consistent with this, genome-scale DNA methylation profiling revealed that MafB imposes an epigenetic program in HS/PCs, and that this program is preserved in mature B cells of MafB-transgenic mice, demonstrating a novel molecular mechanism involved in tumour initiation. Our findings suggest that, mechanistically, the haematopoietic progenitor population can be the target for transformation in MafB-associated plasma cell neoplasias. © 2012 European Molecular Biology Organization | All Rights Reserved.
DescripciónThis article is licensed under a Creative Commons Attribution-NoncommercialNo DerivativeWorks 3.0 Licence.
Versión del editorhttp://dx.doi.org/10.1038/emboj.2012.227
URIhttp://hdl.handle.net/10261/111499
DOI10.1038/emboj.2012.227
Identificadoresissn: 0261-4189
Aparece en las colecciones: (CNB) Artículos
(CBM) Artículos
(IBMCC) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
haematopoieticprogenitors.pdf2,88 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.